iBio (IBIO) Share-based Compensation (2010 - 2026)
iBio's Share-based Compensation was $420,000 in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 55.6% from $270,000 a year earlier and up 11.4% from the prior quarter.
Powered by 
Analysis
iBio (IBIO) Share-based Compensation (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Share-based Compensation at iBio came in at $1.37 million, down 10.3% from FY2025.
- Share-based Compensation has now declined for three consecutive fiscal years, with a five-year compound annual growth rate of -2.8% (FY2021 to FY2026).
- In earlier fiscal years, Share-based Compensation was $1.53 million in FY2025 (-24.9%), $2.04 million in FY2024 (-53.6%), $4.39 million in FY2023 (+0.3%) and $4.38 million in FY2022 (+176.0%).
- The fiscal Q4 2026 figure marks the highest quarterly Share-based Compensation since fiscal Q2 2025.
- Compared with a year earlier, Share-based Compensation was higher in three of the last eight quarters, with an average decline of 12.1%.
- The best year-over-year quarter for Share-based Compensation over five years was fiscal Q2 2022 (growth of 316.2%); the worst was fiscal Q3 2024 (a decline of 71.4%).
- Per Business Quant data, IBIO's Share-based Compensation in the three fiscal quarters before Q4 2026 was $377,000 (Q3 2026), $253,000 (Q2 2026) and $323,000 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | - |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 249.00 Mn |
| 10 | iBio | 87.72 Mn | -177.49 Mn | - | 420,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 420,000.00 |
| Mar 31, 2026 | 377,000.00 |
| Dec 31, 2025 | 253,000.00 |
| Sep 30, 2025 | 323,000.00 |
| Jun 30, 2025 | 270,000.00 |
| Mar 31, 2025 | 370,000.00 |
| Dec 31, 2024 | 475,000.00 |
| Sep 30, 2024 | 415,000.00 |
| Jun 30, 2024 | 360,000.00 |
| Mar 31, 2024 | 454,000.00 |
| Dec 31, 2023 | 454,000.00 |
| Sep 30, 2023 | 765,000.00 |
| Jun 30, 2023 | 446,000.00 |
| Mar 31, 2023 | 385,000.00 |
| Dec 31, 2022 | 915,000.00 |
| Sep 30, 2022 | 1.22 Mn |
| Jun 30, 2022 | 1.18 Mn |
| Mar 31, 2022 | 1.21 Mn |
| Dec 31, 2021 | 960,000.00 |
| Sep 30, 2021 | 821,000.00 |
API Access
iBio Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();